Acute myeloid leukemiaTargeted therapyFLT3 inhibitorsBCL2 inhibitorsIDH inhibitorsHypomethylating agentsThe extensive genomic characterization of acute myeloid leukemia (AML) led to the identification of a vast number of potential therapeutic targets. We review relevant data that have led to recent approval...
Acute myeloid leukemia (AML) also known as acute myelocytic leukemia, acute myelogenous leukemia, acute granulocytic leukemia, and acute non-lymphocytic leukemia.
Acute myeloid leukemia (AML) is the most common acute leukemia in adults. While survival for younger patients over the last several decades has improved nearly sixfold with the optimization of intensive induction chemotherapy and allogeneic stem cell transplantation (alloHSCT), this effect has been l...
said, "Our research highlighted an additional mode of action for the treatment known as eprenetapopt opening up its potential to work in a broader group of acute myeloid leukemia (AML) andmyelodysplastic syndrome(MDS) patients.
New treatments for acute myeloid leukemia: how much has changed?doi:10.1038/s41375-020-01084-2Elihu EsteyLeukemia
Acute myeloid leukemia (AML) is a type of blood cancer.Learn about this cancer that forms in the bone and bone marrow. Treatments include medications and bone marrow transplant.
Acute Myeloid Leukemia (AML) is a type of cancer that affects the blood and bone marrow It occurs when the bone marrow, which is responsible for producing blood cells, starts making too many abnormal white blood cells called myeloblasts.
“Oncogenic fusions are often disease-defining and present a unique marker of leukemic cells that are not usually present in healthy cells. Other diseases such as chronic myeloid leukemia (CML) can already be tracked by the canonical BCR-ABL fusion and sensitively detecting these fusions has ...
This 45-page report provides a behind-the-scenes look at the treatment experience for those living with acute myeloid leukemia (AML). Using detailed quantitative data, it gives a full picture of the AML treatment story - from HCP conversations to t...
and division. Sometimes these enzymes can be overactive, which helps cancer cells survive and multiply. A tyrosine kinase inhibitor (TKI) is a medication given to certain acute myeloid leukemia (AML) patients to block the actions of overactive tyrosine kinases, with the ultimate goal of stopping...